| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |